229 related articles for article (PubMed ID: 9874450)
41. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM
Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803
[TBL] [Abstract][Full Text] [Related]
42. A case of hepatocellular carcinoma that resisted identification.
Cristani A; Cioni G; De Santis M; Vignoli A; Sardini C; Tincani E; Ventura E
Ital J Gastroenterol; 1994; 26(6):303-5. PubMed ID: 7524803
[TBL] [Abstract][Full Text] [Related]
43. Diagnosis of hepatocellular carcinoma.
Gomaa AI; Khan SA; Leen EL; Waked I; Taylor-Robinson SD
World J Gastroenterol; 2009 Mar; 15(11):1301-14. PubMed ID: 19294759
[TBL] [Abstract][Full Text] [Related]
44. Ultrasonographic features of hepatocellular pseudotumour in the cirrhotic liver.
Chang YC; Nagasue N; Kimura N; Ota N; Yukaya H
Clin Radiol; 1988 Nov; 39(6):635-8. PubMed ID: 2468438
[TBL] [Abstract][Full Text] [Related]
45. Serum 90K/MAC-2BP glycoprotein in patients with liver cirrhosis and hepatocellular carcinoma: a comparison with alpha-fetoprotein.
Iacovazzi PA; Trisolini A; Barletta D; Elba S; Manghisi OG; Correale M
Clin Chem Lab Med; 2001 Oct; 39(10):961-5. PubMed ID: 11758611
[TBL] [Abstract][Full Text] [Related]
46. Serum alpha-fetoprotein in the early stage of human hepatocellular carcinoma.
Chen DS; Sung JL; Sheu JC; Lai MY; How SW; Hsu HC; Lee CS; Wei TC
Gastroenterology; 1984 Jun; 86(6):1404-9. PubMed ID: 6201411
[TBL] [Abstract][Full Text] [Related]
47. Early diagnosis of hepatocellular carcinoma.
Okazaki N; Yoshino M; Yoshida T; Takayasu K; Moriyama N; Makuuchi M; Yamazaki S; Hasegawa H; Noguchi M; Hirohashi S
Hepatogastroenterology; 1990 Oct; 37(5):480-3. PubMed ID: 1701411
[TBL] [Abstract][Full Text] [Related]
48. [Hemoperitoneum supporting difficult diagnosis of diffuse hepatocarcinoma in liver cirrhosis].
Vignoli A; Cioni G; Sardini C; Tincani E; Cristani A; Ventura E
Recenti Prog Med; 1994 Apr; 85(4):235-7. PubMed ID: 7517061
[TBL] [Abstract][Full Text] [Related]
49. Transient spontaneous regression of hepatocellular carcinoma.
Magalotti D; Gueli C; Zoli M
Hepatogastroenterology; 1998; 45(24):2369-71. PubMed ID: 9951925
[TBL] [Abstract][Full Text] [Related]
50. Early diagnosis of hepatocellular carcinoma using a sensitive assay for serum des-gamma-carboxy prothrombin: a prospective study.
Ikoma J; Kaito M; Ishihara T; Nakagawa N; Kamei A; Fujita N; Iwasa M; Tamaki S; Watanabe S; Adachi Y
Hepatogastroenterology; 2002; 49(43):235-8. PubMed ID: 11941963
[TBL] [Abstract][Full Text] [Related]
51. Activities of serum enzymes in patients with viral hepatitis B, posthepatitic cirrhosis and hepatocellular carcinoma.
Zheng T; Ren ZY
Chin Med J (Engl); 1990 Sep; 103(9):729-34. PubMed ID: 2174763
[TBL] [Abstract][Full Text] [Related]
52. Hepatocellular carcinoma in primary biliary cirrhosis: detection by alpha-fetoprotein estimation.
Melia WM; Johnson PJ; Neuberger J; Zaman S; Portmann BC; Williams R
Gastroenterology; 1984 Sep; 87(3):660-3. PubMed ID: 6204905
[TBL] [Abstract][Full Text] [Related]
53. [Echographic detection of hepatocellular carcinoma in patients hospitalized for cirrhosis].
Roget L; Coppéré H; Richard P; Barthélém C; Veyret C; Audigier JC
Gastroenterol Clin Biol; 1988 Nov; 12(11):827-32. PubMed ID: 2464520
[TBL] [Abstract][Full Text] [Related]
54. Alpha-1-fucosidase as a prognostic indicator for hepatocellular carcinoma following hepatectomy: a large-scale, long-term study.
Wang K; Guo W; Li N; Shi J; Zhang C; Lau WY; Wu M; Cheng S
Br J Cancer; 2014 Apr; 110(7):1811-9. PubMed ID: 24569461
[TBL] [Abstract][Full Text] [Related]
55. Depressed immune function in patients with cirrhosis before emergence of hepatocellular carcinoma.
Saibara T; Maeda T; Miyazaki M; Onishi S; Yamamoto Y
Hepatology; 1993 Aug; 18(2):315-9. PubMed ID: 7687981
[TBL] [Abstract][Full Text] [Related]
56. Value of the serum alpha-L-fucosidase activity in the diagnosis of colorectal cancer.
Ayude D; Fernández-Rodríguez J; Rodríguez-Berrocal FJ; Martínez-Zorzano VS; de Carlos A; Gil E; Páez de La Cadena M
Oncology; 2000 Nov; 59(4):310-6. PubMed ID: 11096343
[TBL] [Abstract][Full Text] [Related]
57. Screening for hepatocellular carcinoma.
De Masi S; Tosti ME; Mele A
Dig Liver Dis; 2005 Apr; 37(4):260-8. PubMed ID: 15788210
[TBL] [Abstract][Full Text] [Related]
58. Clinicopathologic features and risk factors for hepatocellular carcinoma: results from a single center in southern Turkey.
Ozer B; Serin E; Yilmaz U; Gümürdülü Y; Saygili OB; Kayaselçuk F; Boyacioğlu S
Turk J Gastroenterol; 2003 Jun; 14(2):85-90. PubMed ID: 14614632
[TBL] [Abstract][Full Text] [Related]
59. [Diagnostic value of serum alpha-L-fucosidase in primary hepatic carcinoma].
Ke JL
Zhonghua Yi Xue Za Zhi; 1989 Mar; 69(3):153-5. PubMed ID: 2776057
[No Abstract] [Full Text] [Related]
60. [Diagnosis of hepatocellular carcinoma performed by searching for serologic tumor markers].
de Oliveira e Silva A; Roldan-Molina F; dos Santos TE; Santo GC; Miranda MP; Genzini T; Neves LB; D'Albuquerque LA
Arq Gastroenterol; 1990; 27(2):83-94. PubMed ID: 1709803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
